Randomised evaluation of assertive community treatment (REACT) services in London

ISRCTN	ISRCTN55715361
DOI	https://doi.org/10.1186/ISRCTN55715361
Secondary identifying numbers	N0053056706

Submission date: 12/09/2003
Registration date: 12/09/2003
Last edited: 02/07/2009

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Mental and Behavioural Disorders

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sonia Johnson
Scientific

Department of Psychiatry and Behavioural Sciences
University College London Medical School
Wolfson Buiding
48 Riding House Street
London
W1N 8AA
United Kingdom

Phone	+44 020 7527 8805
Email	s.johnson@ucl.ac.uk

Study information

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Other
Study type	Not Specified
Scientific title
Study objectives	The aim of the study is to assess the effectiveness of Assertive Community Treatment (ACT) as a way of engaging individuals with severe mental illnesses who engage poorly with standard community services.
Ethics approval(s)	Camden and Islington Community and Royal Free Hospital local research ethics committees.
Health condition(s) or problem(s) studied	Mental and Behavioural Disorders
Intervention	Interviews. Randomised Controlled Trial: A. Assertive Community Treatment B. Normal Care
Intervention type	Other
Primary outcome measure	Assertive Community Treatment (ACT) is an important and promising model, in that it has the potential to meet the needs of a particularly chaotic client group to whom standard community based services currently struggle to deliver services. The results should inform policy makers, local service commissioners and providers of health services in metropolitan areas in the UK.
Secondary outcome measures	Not provided at time of registration
Overall study start date	01/11/1999
Completion date	31/01/2004

Eligibility

Participant type(s)	Patient
Age group	Not Specified
Sex	Both
Target number of participants	251
Key inclusion criteria	1. Living in independent or low supported accommodation within the London boroughs of Camden and Islington 2. Under the care of the community mental health team for at least 12 months 3. Identified as having difficulty engaging with standard community care 4. Primary diagnosis of serious mental illness (for example, schizophrenia, schizoaffective disorder, other chronic psychosis, bipolar affective disorder) 5. Recent high use of inpatient care (at least 100 consecutive inpatient days or at least five admissions within the past two years or at least 50 consecutive inpatient days or at least three admissions within the past year) 6. Individuals with concurrent problems from substance misuse or personality disorder were eligible if these were secondary diagnoses
Key exclusion criteria	Patients with organic brain damage
Date of first enrolment	01/11/1999
Date of final enrolment	31/01/2004

Locations

Countries of recruitment

England
United Kingdom

Study participating centre

Department of Psychiatry and Behavioural Sciences

London
W1N 8AA
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website	http://www.doh.gov.uk

Funders

Funder type

Government

Camden and Islington Health Authority, the Kings Fund, and the

No information available

Department of Health.

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	08/04/2006		Yes	No
Results article	results	01/07/2009		Yes	No